May 17, 2013 From NYC Mayor’s office
It is my pleasure to welcome you to the May 2013 Frankfurt Medtech Program. The NYC Medtech Program regularly brings together collaborators in the life science, biotech, device and pharma industries, and the Frankfurt program will provide opportunities for companies in both Germany and the U.S. In New York City, the Bloomberg Administration is committed to bringing together public and private resources to invest in technologies such as bioscience to transform our City’s economy.
New York City is working to create a powerful biotech industry with new resources to encourage commercialization of the research that is done in our many universities and hospitals. Initiatives include the development of real estate facilities, training programs, and funding. In 2010 the Alexandria Center for Life Sciences opened a 300,000 square foot tower on Manhattan’s east side with both wet lab and administrative office space. The second phase is currently under development and will add a 410,000 square foot laboratory and office building. The City is also working with the State University of New York (SUNY) Downstate as it develops the BioBAT facility in Brooklyn. This year BioBAT will finish development of 60,000 square feet of wet lab and office space, and the facility will ultimately provide 500,000 square feet of commercial biotech space.
The new headquarters for the New York Genome Center (NYGC) is scheduled to open later this year in lower Manhattan. The Center will be a world-class hub for genome sequencing, analytics, bioinformatics, high performance computing, and translational research. NYGC will leverage New York’s vast academic and research infrastructure; serve as a collaboration nexus for pharmaceutical, biotech, and IT companies; and catalyze the formation of new innovations and start-up enterprises. In March of this year Mayor Bloomberg spoke at the commissioning of Intergate Manhattan, the largest high-rise data center in the world, which will house the Genome Center’s data. The funding for NYGC has come from a number of public, private, and philanthropic sources, including low-cost financing from the City.
To assist local researchers with funding proposals, the City’s Economic Development Corporation (EDC) holds regular training sessions for biotech firms applying for Small Business Innovation Research grants from the federal government. Other programs to promote innovation in the healthcare sector include the Pilot Health Tech NY program that provides funding of up to $100,000 to innovative projects in healthcare technology, and the New York Digital Health Accelerator for early- and growth-stage digital health companies.
NYC Tech Connect launched in January 2011 as a public-private partnership funded jointly by the Partnership Fund for New York City, the Partnership for New York City and the New York City Council. NYC Tech Connect actively promotes entrepreneurship in the hard sciences and organizes the Riverside Chats Speakers Series, the NYC Emerging Technologies Summit, and other events. The website provides a useful list of resources in NYC for bioscience and technology companies.
For up-to-date information on New York City’s bioscience initiatives, sign up for the NYC Bioscience Newsletter at www.nycbiotech.org. For direct assistance, the Division for International Business in the New York City Mayor’s Office provides customized service to overseas companies interested in opening an office in New York City. We are ready to assist any company in joining our City’s top technology and engineering talent, and I look forward to hearing from you. I wish you great success at the Frankfurt MedTech Program.
C. Carlton Vann